NASDAQ: AFIBAcutus Medical Inc Stock Ownership - Who owns Acutus Medical?
Insider buying vs selling
Have Acutus Medical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Takeo Mukai | CFO | 2024-03-01 | 8,475 | $0.21 | $1.78kSell |
| Tom Sohn | SVP Gen. Counsel Secretary | 2024-02-06 | 7,582 | $0.17 | $1.31kSell |
| Takeo Mukai | CFO | 2024-02-01 | 2,869 | $0.19 | $547.98Sell |
| Tom Sohn | SVP Gen. Counsel Secretary | 2024-02-01 | 5,709 | $0.19 | $1.09kSell |
| Kevin Mathews | SVP Commercial | 2024-01-07 | 6,342 | $0.19 | $1.20kSell |
| David Roman | President CEO | 2024-01-07 | 24,086 | $0.19 | $4.55kSell |
| Takeo Mukai | CFO | 2023-09-01 | 1,729 | $0.49 | $843.75Sell |
| Kevin Mathews | SVP Commercial | 2023-08-05 | 134 | $0.69 | $92.46Sell |
| Tom Sohn | SVP Gen. Counsel Secretary | 2023-08-05 | 433 | $0.69 | $298.77Sell |
| David Roman | President CEO | 2023-06-01 | 17,290 | $0.85 | $14.66kSell |
AFIB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AFIB insiders and whales buy or sell their stock.
AFIB Shareholders
What type of owners hold Acutus Medical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 8.98% | 2,669,208 | $464.44k | Insider |
| Deerfield Management Company LP Series C | 8.95% | 2,660,808 | $462.98k | Institution |
| Orbimed Advisors LLC | 8.91% | 2,648,386 | $460.82k | Institution |
| David P. Bonita | 5.71% | 1,698,183 | $295.48k | Insider |
| Shahzad Malik | 5.24% | 1,555,735 | $270.70k | Insider |
| R. Scott Huennekens | 1.78% | 529,349 | $92.11k | Insider |
| David Roman | 1.12% | 332,134 | $57.79k | Insider |
| Renaissance Technologies LLC | 1.10% | 327,000 | $56.90k | Institution |
| Vanguard Group Inc | 0.96% | 286,084 | $49.78k | Institution |
| Blackrock Inc | 0.70% | 206,681 | $35.96k | Institution |
AFIB vs Medical Device Stocks
Acutus Medical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.